Amedisys (AMED) Reports In-Line Q1 EPS

Amedisys (NASDAQ: AMED) reported Q1 EPS of $0.33, in-line with the analyst estimate of $0.33. Revenue for the quarter came in at $348.8 million versus the consensus estimate of $337.07 million.

For earnings history and earnings-related data on Amedisys (AMED) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• Ennis (EBF) Misses Q2 EPS by 2c